Welcome to LookChem.com Sign In|Join Free

CAS

  • or
2-Hydroxybenzimidazole is an organic compound with the chemical formula C7H6N2O2. It is a white crystalline solid and is a metabolite of the neuroleptic Droperidol (D679500). It is also known as Lansoprazole EP Impurity D and Rabeprazole EP Impurity K.

615-16-7 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 615-16-7 Structure
  • Basic information

    1. Product Name: 2-Hydroxybenzimidazole
    2. Synonyms: o-phenylene urea;RARECHEM AQ NN 0099;TIMTEC-BB SBB004209;TIMTEC-BB SBB000067;1,3-dihydro-2h-benzimidazol-2-on;2(3H)-Oxobenzimidazole;2-alpha-Hydroxybenzimidazole;2,3-Dihydro-2-oxo-1H-benzimidazole
    3. CAS NO:615-16-7
    4. Molecular Formula: C7H6N2O
    5. Molecular Weight: 134.14
    6. EINECS: 210-412-4
    7. Product Categories: API intermediates;Intermediates & Fine Chemicals;Metabolites & Impurities;Pharmaceuticals;Benzimidazoles;Bioactive Small Molecules;Building Blocks;Cell Biology;Chemical Synthesis;H;Heterocyclic Building Blocks;Metabolites & Impurities, Pharmaceuticals, Intermediates & Fine Chemicals;pharmaceutical;BENZIMIDAZOLE;PHARMACEUTICAL INTERMEDIATES;Benzimidazole Series;Imidazoles, Pyrroles, Pyrazoles, Pyrrolidines;Imidazol&Benzimidazole
    8. Mol File: 615-16-7.mol
  • Chemical Properties

    1. Melting Point: >300 °C(lit.)
    2. Boiling Point: 247.23°C (rough estimate)
    3. Flash Point: 42.6 °C
    4. Appearance: Off-white to pale brown/Crystalline Powder
    5. Density: 1.2296 (rough estimate)
    6. Refractive Index: 1.5880 (estimate)
    7. Storage Temp.: Store below +30°C.
    8. Solubility: 0.543g/l
    9. PKA: 11.95±0.10(Predicted)
    10. Water Solubility: insoluble
    11. BRN: 119866
    12. CAS DataBase Reference: 2-Hydroxybenzimidazole(CAS DataBase Reference)
    13. NIST Chemistry Reference: 2-Hydroxybenzimidazole(615-16-7)
    14. EPA Substance Registry System: 2-Hydroxybenzimidazole(615-16-7)
  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: 36/37/38
    3. Safety Statements: 22-24/25-37/39
    4. WGK Germany: 1
    5. RTECS: DE1625000
    6. TSCA: Yes
    7. HazardClass: N/A
    8. PackingGroup: N/A
    9. Hazardous Substances Data: 615-16-7(Hazardous Substances Data)

615-16-7 Usage

Uses

Used in Pharmaceutical Industry:
2-Hydroxybenzimidazole is used as an impurity in the synthesis of proton pump inhibitors such as Lansoprazole and Rabeprazole. It plays a crucial role in the development and quality control of these medications, ensuring their safety and efficacy.
Used in Metabolite Research:
As a metabolite of the neuroleptic Droperidol, 2-Hydroxybenzimidazole is utilized in research to understand the metabolic pathways and pharmacokinetics of the drug. This knowledge can help in the development of new drugs with improved therapeutic properties and reduced side effects.

Synthesis Reference(s)

The Journal of Organic Chemistry, 33, p. 2543, 1968 DOI: 10.1021/jo01270a093Synthesis, p. 322, 1991 DOI: 10.1055/s-1991-26457Tetrahedron Letters, 22, p. 2431, 1981 DOI: 10.1016/S0040-4039(01)92925-9

Safety Profile

Moderately toxic by subcutaneous route. When heated to decomposition it emits toxic vapors of NOx.

Check Digit Verification of cas no

The CAS Registry Mumber 615-16-7 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 6,1 and 5 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 615-16:
(5*6)+(4*1)+(3*5)+(2*1)+(1*6)=57
57 % 10 = 7
So 615-16-7 is a valid CAS Registry Number.
InChI:InChI=1/C7H6N2O/c10-7-8-5-3-1-2-4-6(5)9-7/h1-4H,(H2,8,9,10)

615-16-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A18324)  2-Hydroxybenzimidazole, 98%   

  • 615-16-7

  • 10g

  • 397.0CNY

  • Detail
  • Alfa Aesar

  • (A18324)  2-Hydroxybenzimidazole, 98%   

  • 615-16-7

  • 50g

  • 1481.0CNY

  • Detail
  • Alfa Aesar

  • (A18324)  2-Hydroxybenzimidazole, 98%   

  • 615-16-7

  • 100g

  • 2083.0CNY

  • Detail
  • Alfa Aesar

  • (A18324)  2-Hydroxybenzimidazole, 98%   

  • 615-16-7

  • 250g

  • 4641.0CNY

  • Detail

615-16-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-Hydroxybenzimidazole

1.2 Other means of identification

Product number -
Other names 2-HYDROXYBENZIMIDAZOLE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:615-16-7 SDS

615-16-7Synthetic route

1,2-diamino-benzene
95-54-5

1,2-diamino-benzene

1,1'-carbonyldiimidazole
530-62-1

1,1'-carbonyldiimidazole

1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 20℃; for 18h;99%
at 20℃; for 22h;96%
In N,N-dimethyl-formamide at 0 - 20℃; for 24h; Inert atmosphere;81%
anthranilic hydroxamic acid
5623-04-1

anthranilic hydroxamic acid

1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

Conditions
ConditionsYield
In formamide at 130℃; for 0.333333h;99%
at 150 - 170℃;
carbon monoxide
201230-82-2

carbon monoxide

1,2-diamino-benzene
95-54-5

1,2-diamino-benzene

1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

Conditions
ConditionsYield
With 1-Methylpyrrolidine; selenium In tetrahydrofuran at 100℃; under 22800.7 Torr; for 20h;99%
With carbon dioxide; oxygen; potassium iodide; palladium(II) iodide In 1,2-dimethoxyethane at 100℃; under 45600 Torr; for 2h;99%
With 1-Methylpyrrolidine; selenium; oxygen In tetrahydrofuran 1.) 31 kg/cm2, 100 degC, 20 h, 2.) 25 degC, 1 h;99%
5-phenyl-3H-[1,3,4]oxadiazol-2-one
1199-02-6

5-phenyl-3H-[1,3,4]oxadiazol-2-one

1,2-diamino-benzene
95-54-5

1,2-diamino-benzene

A

1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

B

benzoic acid hydrazide
613-94-5

benzoic acid hydrazide

Conditions
ConditionsYield
In various solvent(s) at 150℃; for 5h;A 98%
B n/a
1,2-diamino-benzene
95-54-5

1,2-diamino-benzene

1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

Conditions
ConditionsYield
In N-methyl-acetamide; ethyl acetate98%
Multi-step reaction with 2 steps
1: benzene
2: 183 °C
View Scheme
Multi-step reaction with 2 steps
1: water
2: 150 °C
View Scheme
phenyl isocyanate
103-71-9

phenyl isocyanate

1,2-diamino-benzene
95-54-5

1,2-diamino-benzene

1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

Conditions
ConditionsYield
With tris(bis(trimethylsilyl)amido)lanthanum(III) In toluene at 80℃; for 24h; Catalytic behavior; Reagent/catalyst; Temperature; Time; Solvent; Inert atmosphere; Schlenk technique; chemoselective reaction;96%
In N,N-dimethyl acetamide for 0.183333h; Irradiation;82%
carbon dioxide
124-38-9

carbon dioxide

1,2-diamino-benzene
95-54-5

1,2-diamino-benzene

1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

Conditions
ConditionsYield
In tetrahydrofuran; water at 20℃; under 7500.75 Torr; for 9h; UV-irradiation;96%
With Sn(IV)-doped DFNS supported CdSnO3 nanoparticles under 11251.1 Torr; for 1h; Kinetics; UV-irradiation;96%
With cesium fluoride In diethylene glycol dimethyl ether at 100℃; for 20h; Glovebox; Schlenk technique;95%
1-(N-carbethoxyimidoyl)-2-benzimidazolone
144167-52-2

1-(N-carbethoxyimidoyl)-2-benzimidazolone

1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

Conditions
ConditionsYield
at 200℃; high vacuum sublimation;95%
at 200℃; Product distribution; high vacuum sublimation; or with acid; other 1-(N-carbethoxyimidoyl)-2-benzimidazolones;95%
(2‑aminophenyl)(1H‑benzo[d][1,2,3]triazol‑1‑yl)methanone
117576-29-1

(2‑aminophenyl)(1H‑benzo[d][1,2,3]triazol‑1‑yl)methanone

1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

Conditions
ConditionsYield
With trimethylsilylazide; triethylamine; aniline In toluene at 110℃; for 1h; Sealed tube;95%
1,2-diamino-benzene
95-54-5

1,2-diamino-benzene

urea
57-13-6

urea

1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 135 - 140℃; for 12h;94%
With sulfated polyborate at 120℃; for 1.5h;94%
With acetic acid In tetrahydrofuran; water at 100 - 135℃; for 5h; Inert atmosphere;93.7%
5-(4-chlorophenyl)-3H-[1,3,4]oxadiazol-2-one
1711-61-1

5-(4-chlorophenyl)-3H-[1,3,4]oxadiazol-2-one

1,2-diamino-benzene
95-54-5

1,2-diamino-benzene

1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

Conditions
ConditionsYield
In N,N-dimethyl acetamide for 0.133333h; Irradiation;93%
carbon monoxide
201230-82-2

carbon monoxide

2-nitro-aniline
88-74-4

2-nitro-aniline

1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

Conditions
ConditionsYield
With selenium; 1,8-diazabicyclo[5.4.0]undec-7-ene; triethylamine In toluene at 150℃; under 22800 Torr; for 4h;92%
With tin(IV) chloride; triethylamine; bis(triphenylphosphine)platinum(II) dichloride In 1,4-dioxane at 140℃; for 4h;56%
anthranilic acid amide
28144-70-9

anthranilic acid amide

1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

Conditions
ConditionsYield
With iodosylbenzene In dichloromethane at 20℃; for 2h; Hofmann rearrangement;92%
With potassium hydroxide; [bis(acetoxy)iodo]benzene In methanol at 0℃; for 1h;82%
p-Tolylisocyanate
622-58-2

p-Tolylisocyanate

1,2-diamino-benzene
95-54-5

1,2-diamino-benzene

1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

Conditions
ConditionsYield
With tris(bis(trimethylsilyl)amido)lanthanum(III) In toluene at 80℃; for 24h; Inert atmosphere; Schlenk technique; chemoselective reaction;92%
5-phenyl-1H-tetrazolone
5097-82-5

5-phenyl-1H-tetrazolone

1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

Conditions
ConditionsYield
In acetonitrile at 20℃; for 16h; Irradiation;90%
1-benzoyl-4-(o-aminophenyl)semicarbazide
120811-68-9

1-benzoyl-4-(o-aminophenyl)semicarbazide

1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

Conditions
ConditionsYield
In various solvent(s) at 150℃; for 5h;90%
phenyl 4,5-dichloro-6-oxopyridazine-1(6H)-carboxylate
1202680-24-7

phenyl 4,5-dichloro-6-oxopyridazine-1(6H)-carboxylate

1,2-diamino-benzene
95-54-5

1,2-diamino-benzene

1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

Conditions
ConditionsYield
In toluene for 11h; Solvent; Reflux; Green chemistry;90%
diphenylcarbamic chloride
83-01-2

diphenylcarbamic chloride

1,2-diamino-benzene
95-54-5

1,2-diamino-benzene

1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

Conditions
ConditionsYield
In N,N-dimethyl acetamide for 0.0666667h; Irradiation;89%
di(succinimido) carbonate
74124-79-1

di(succinimido) carbonate

1,2-diamino-benzene
95-54-5

1,2-diamino-benzene

1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

Conditions
ConditionsYield
In acetonitrile for 8h; Ambient temperature;88%
1,2-diamino-benzene
95-54-5

1,2-diamino-benzene

carbonic acid dimethyl ester
616-38-6

carbonic acid dimethyl ester

A

1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

B

1,3-dimethyl-1,3-dihydrobenzimidazol-2-one
3097-21-0

1,3-dimethyl-1,3-dihydrobenzimidazol-2-one

C

N-methyl-1,2-phenylenediamine
4760-34-3

N-methyl-1,2-phenylenediamine

Conditions
ConditionsYield
With lead(II) nitrate at 169.85℃; for 0.5h;A 88%
B n/a
C n/a
S,S
32276-00-9

S,S"-bis(1-phenyl-1H-tetrazol-5-yl) dithiocarbonate

1,2-diamino-benzene
95-54-5

1,2-diamino-benzene

A

1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

B

1-Phenyl-1H-tetrazole-5-thiol
86-93-1

1-Phenyl-1H-tetrazole-5-thiol

Conditions
ConditionsYield
In acetonitrile for 12h;A 87%
B n/a
1,3-dicarbethoxy-S-methylisothiourea
34840-26-1

1,3-dicarbethoxy-S-methylisothiourea

1,2-diamino-benzene
95-54-5

1,2-diamino-benzene

1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

Conditions
ConditionsYield
In N,N-dimethyl-formamide for 3h; Heating;85%
1,3-Dicarbomethoxy-S-methylisothiourea
34840-23-8

1,3-Dicarbomethoxy-S-methylisothiourea

1,2-diamino-benzene
95-54-5

1,2-diamino-benzene

1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

Conditions
ConditionsYield
In N,N-dimethyl-formamide for 3h; Heating;85%
sodium isocyanate
917-61-3

sodium isocyanate

1,2-diamino-benzene
95-54-5

1,2-diamino-benzene

1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

Conditions
ConditionsYield
In N,N-dimethyl acetamide for 0.0666667h; Irradiation;81%
anthranilic acid
118-92-3

anthranilic acid

1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

Conditions
ConditionsYield
With sodium azide; ammonium chloride; trichlorophosphate; N,N-dimethyl-formamide at 0 - 20℃; Curtius rearrangement;80%
With polymer-supported diphenylphosphoryl azide; triethylamine In benzene for 24h; Heating;75%
1,2-diamino-benzene
95-54-5

1,2-diamino-benzene

ethyl cyanoformate
623-49-4

ethyl cyanoformate

1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

Conditions
ConditionsYield
With lithium bromide In 1,4-dioxane at 100 - 105℃; for 1h;78%
(2-oxo-2,3-dihydro-1H-benz[d]imidazol-1-yl)(phenyl)methyl acetate

(2-oxo-2,3-dihydro-1H-benz[d]imidazol-1-yl)(phenyl)methyl acetate

1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

Conditions
ConditionsYield
With hydrogenchloride In water; isopropyl alcohol at 70℃; for 1h;76%
3‐acetyl‐2‐hydroxy‐6‐methyl‐4H‐pyran‐4‐one
16807-48-0

3‐acetyl‐2‐hydroxy‐6‐methyl‐4H‐pyran‐4‐one

1,2-diamino-benzene
95-54-5

1,2-diamino-benzene

A

2-Methyl-1H-benzimidazole
615-15-6

2-Methyl-1H-benzimidazole

B

1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

C

4-(2-oxopropylidene)-1,2,4,5-tetrahydro-1H-1,5-benzodiazepin-2-one
111008-23-2

4-(2-oxopropylidene)-1,2,4,5-tetrahydro-1H-1,5-benzodiazepin-2-one

Conditions
ConditionsYield
In xylene Heating; 1:1 molar ratio;A n/a
B n/a
C 75%
carbon dioxide
124-38-9

carbon dioxide

1,2-bis(trimethylsilylamino)benzene
13435-10-4

1,2-bis(trimethylsilylamino)benzene

1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

Conditions
ConditionsYield
With pyridine; C14H34Cl2InNO2Si2 In toluene at 110℃; under 2280.15 Torr; for 12h;73%
1,2-diamino-benzene
95-54-5

1,2-diamino-benzene

5-phenyl-1,3,4-oxathiazol-2-one
5852-49-3

5-phenyl-1,3,4-oxathiazol-2-one

1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide for 0.5h; Ambient temperature;72.5%
1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

benzimidazolin-2-one disodium salt
85694-84-4, 86100-43-8

benzimidazolin-2-one disodium salt

Conditions
ConditionsYield
With sodium ethanolate In ethanol for 0.5h;100%
1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

carbonic acid dimethyl ester
616-38-6

carbonic acid dimethyl ester

1,3-dimethyl-1,3-dihydrobenzimidazol-2-one
3097-21-0

1,3-dimethyl-1,3-dihydrobenzimidazol-2-one

Conditions
ConditionsYield
With lead(II) nitrate at 199.85℃; for 20h;100%
1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

isopentanoyl chloride
108-12-3

isopentanoyl chloride

5-isovalerylbenzimidazolin-2-one
93202-27-8

5-isovalerylbenzimidazolin-2-one

Conditions
ConditionsYield
With aluminium trichloride In 1,1,2,2-tetrachloroethylene at 90 - 100℃; for 1h;98%
With carbon disulfide; aluminium trichloride
1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

chloroacetyl chloride
79-04-9

chloroacetyl chloride

5-(2-chloroethanoyl)-1,3-dihydrobenzimidazol-2-one
93202-41-6

5-(2-chloroethanoyl)-1,3-dihydrobenzimidazol-2-one

Conditions
ConditionsYield
With aluminium trichloride In 1,1,2,2-tetrachloroethylene at 90 - 100℃; for 1h;98%
With aluminum (III) chloride In 1,1,2,2-tetrachloroethane at 100℃; for 1h; Cooling with ice;93%
1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

2,3-Dihydro-2-oxo-1H-benzimidazole-1,3-(2H)-dicarboxylic acid bis(1,1-dimethylethyl ester)
161468-58-2

2,3-Dihydro-2-oxo-1H-benzimidazole-1,3-(2H)-dicarboxylic acid bis(1,1-dimethylethyl ester)

Conditions
ConditionsYield
With dmap In tetrahydrofuran for 1h; Heating;98%
1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

5,6-dichloro-1,3-dihydrobenzoimidazol-2-one
2033-29-6

5,6-dichloro-1,3-dihydrobenzoimidazol-2-one

Conditions
ConditionsYield
With sulfuryl dichloride In acetic acid Ambient temperature;98%
With N-chloro-succinimide In N,N-dimethyl-formamide at 20℃; for 6h; Inert atmosphere;97%
1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

4-nitro-benzoyl chloride
122-04-3

4-nitro-benzoyl chloride

1-(4-nitrobenzoyl)-1,3-dihydrobenzimidazol-2-one
1240613-76-6

1-(4-nitrobenzoyl)-1,3-dihydrobenzimidazol-2-one

Conditions
ConditionsYield
With pyridine at 0 - 80℃; for 4.25h;98%
1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

2-chloropropionyl chloride
7623-09-8

2-chloropropionyl chloride

5-(2-chloropropanoyl)-1,3-dihydro-2H-benzo[d]imidazol-2-one

5-(2-chloropropanoyl)-1,3-dihydro-2H-benzo[d]imidazol-2-one

Conditions
ConditionsYield
With aluminum (III) chloride In dichloromethane at 5 - 25℃; for 19h; Friedel-Crafts Alkylation; Inert atmosphere; regioselective reaction;98%
1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

acetic anhydride
108-24-7

acetic anhydride

1,3-diacetyl-1,3-dihydro-benzoimidazol-2-one
2735-73-1

1,3-diacetyl-1,3-dihydro-benzoimidazol-2-one

Conditions
ConditionsYield
for 6h; Heating;97%
1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

2-chloro-1H-benzoimidazole
4857-06-1

2-chloro-1H-benzoimidazole

Conditions
ConditionsYield
With trichlorophosphate; phenol at 103 - 107℃; for 12h;97%
With trichlorophosphate at 100℃; for 15h;91%
With trichlorophosphate In neat (no solvent)80%
1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

5,6-anhydro-1,2-O-isopropylidene-α-D-glucofuranose
15354-69-5

5,6-anhydro-1,2-O-isopropylidene-α-D-glucofuranose

1,3-N,N'-bis-(6-deoxy-1,2-O-isopropylidene-α-D-glucofuranos-6-yl)benzimidazol-2-one
869104-29-0

1,3-N,N'-bis-(6-deoxy-1,2-O-isopropylidene-α-D-glucofuranos-6-yl)benzimidazol-2-one

Conditions
ConditionsYield
With potassium carbonate In dimethyl sulfoxide; toluene at 100℃; for 2h;97%
1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

chloroacetic acid ethyl ester
105-39-5

chloroacetic acid ethyl ester

diethyl 2,2'-(2-oxo-1H-benzimidazole-1,3[2H]-diyl)diacetate
83330-80-7

diethyl 2,2'-(2-oxo-1H-benzimidazole-1,3[2H]-diyl)diacetate

Conditions
ConditionsYield
With sodium hydride In neat (no solvent) for 0.333333h; Milling; Green chemistry;97%
1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

isobutyryl chloride
79-30-1

isobutyryl chloride

5-isobutyrylbenzimidazolin-2-one
93202-43-8

5-isobutyrylbenzimidazolin-2-one

Conditions
ConditionsYield
With aluminium trichloride In 1,1,2,2-tetrachloroethylene at 90 - 100℃; for 1h;96%
1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

2,3-Dihydro-2-oxo-1H-benzimidazole-1,3-(2H)-dicarboxylic acid bis(1,1-dimethylethyl ester)
161468-58-2

2,3-Dihydro-2-oxo-1H-benzimidazole-1,3-(2H)-dicarboxylic acid bis(1,1-dimethylethyl ester)

2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxylic acid 1,1-dimethylethyl ester
161468-45-7

2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxylic acid 1,1-dimethylethyl ester

Conditions
ConditionsYield
With potassium carbonate In acetonitrile Heating;96%
1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

ethyl bromide
74-96-4

ethyl bromide

1,3-diethyl-1,3-dihydro-2H-benzimidazol-2-one
6648-01-7

1,3-diethyl-1,3-dihydro-2H-benzimidazol-2-one

Conditions
ConditionsYield
With sodium hydroxide; tetrabutyl-ammonium chloride In benzene at 60℃; for 5h;95%
1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

propionyl chloride
79-03-8

propionyl chloride

5-propionylbenzimidazolin-2-one
93202-42-7

5-propionylbenzimidazolin-2-one

Conditions
ConditionsYield
With aluminium trichloride In 1,1,2,2-tetrachloroethylene at 90 - 100℃; for 1h;95%
1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

methyl iodide
74-88-4

methyl iodide

1,3-dimethyl-1,3-dihydrobenzimidazol-2-one
3097-21-0

1,3-dimethyl-1,3-dihydrobenzimidazol-2-one

Conditions
ConditionsYield
With sodium hydroxide; tetrabutyl-ammonium chloride In benzene at 60℃; for 5h;95%
Stage #1: 1,3-dihydro-2H-benzimidazol-2-one With sodium hydride In N,N-dimethyl-formamide; mineral oil at 0℃; for 0.25h;
Stage #2: methyl iodide In N,N-dimethyl-formamide; mineral oil at 20℃; for 12h;
83%
With potassium carbonate In N,N-dimethyl-formamide at 20℃;79%
1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

diethyl dicarbonate
1609-47-8

diethyl dicarbonate

2-oxo-benzoimidazole-1,3-dicarboxylic acid diethyl ester
161468-57-1

2-oxo-benzoimidazole-1,3-dicarboxylic acid diethyl ester

Conditions
ConditionsYield
With dmap In tetrahydrofuran for 0.5h;95%
1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

acetyl chloride
75-36-5

acetyl chloride

1,3-diacetyl-1,3-dihydro-benzoimidazol-2-one
2735-73-1

1,3-diacetyl-1,3-dihydro-benzoimidazol-2-one

Conditions
ConditionsYield
With triethylamine for 5h; Heating;94%
With pyridine
1,3-dihydro-2H-benzimidazol-2-one
615-16-7

1,3-dihydro-2H-benzimidazol-2-one

ethyl pyridine-2-yl carbonate
7325-39-5

ethyl pyridine-2-yl carbonate

ethyl 2-oxo-2,3-dihydro-1H-benzo[d]imidazole-1-carboxylate
41120-23-4

ethyl 2-oxo-2,3-dihydro-1H-benzo[d]imidazole-1-carboxylate

Conditions
ConditionsYield
With potassium carbonate In acetonitrile for 0.5h; Heating;94%
With potassium carbonate In acetonitrile for 2h; Reflux; Inert atmosphere;87%

615-16-7Relevant articles and documents

Synthesis of bis(2-imino-1,3-dimethylbenzimidazoline)s via reactions of a solvothermally prepared benzimidazolium chloride and diamines

Zuo, Shengli,Zhang, Fan,Liu, Jianjun,Zuo, Ang

, (2021)

The first solvothermal preparation of benzimidazolium chloride for the synthesis of bis(2-imino-1,3-dimethylbenzimidazoline) derivatives from readily available diamines is reported, including an optimized preparation of previously reported solvothermal synthesis of the benzimidazolium intermediate. Several primary diamines including both aliphatic and aromatic linkers were converted to the corresponding bis(guanidine)s in moderate to good yield.

Preparation of 2(3H)-benzimidazolone and its derivative under aqueous condition as a potential agent for antidiabetic compounds

Abbas, Muhammad Azhar,Hameed, Shahid,Kressler, Joerg

, p. 509 - 511 (2013)

A focused library of 2(3H)-benzimidazolone and its derivatives has been synthesized in an attempt to identify their antidiabetic potential. All the products have been synthesized under aqueous conditions in lesser time with better yield and purity. A new effective and convenient method for in situ synthesis of five member heterocyclic ring by reaction of phenylene diamine with urea in solvent phase. All the synthesized compounds were characterized by modern spectroscopic techniques.

Indium(III)-Catalyzed Synthesis of Primary Carbamates and N-Substituted Ureas

Jain, Isha,Malik, Payal

supporting information, p. 93 - 97 (2021/11/26)

An indium triflate-catalyzed synthesis of primary carbamates from alcohols and urea as an ecofriendly carbonyl source has been developed. Various linear, branched, and cyclic alcohols were converted into the corresponding carbamates in good to excellent yields. This method also provided access to N-substituted ureas by carbamoylation of amines. All the products were obtained by simple filtration or crystallization, without the need for chromatographic purification. Mechanistic investigations suggest that the carbamoylation reaction proceeds through activation of urea by O-coordination with indium, followed by nucleophilic attack by the alcohol or amine on the carbonyl center of urea. The inexpensive and easily available starting materials and catalyst, the short reaction times, and the ease of product isolation highlight the inherent practicality of the developed method.

PrVO4/SnD NPs as a Nanocatalyst for Carbon Dioxide Fixation to Synthesis Benzimidazoles and 2-Oxazolidinones

He, Zemin,Yu, Ping,Zhao, Yuzhen,Zhang, Huimin,Zhang, Yongming,Kang, Xiaoxi,Zhang, Haiquan,Sadeghzadeh, Seyed Mohsen

, p. 1623 - 1632 (2020/10/19)

Recently CO2 stabilization has received a great deal of attention because of its probable applications as a rich C1 resource and the synthesis of several fine chemicals can be accomplished through this stabilization. In this study, Sn(IV) doping dendritic fibrous nanosilica (SnD) supported PrVO4 nanoparticles as a catalyst (PrVO4/SnD) was synthesized by a in-situ procedure. The SnD with the ratios of Si/Sn in a variety of 6 to 40 were acquired through direct hydrothermal synthesis (DHS), and PrVO4 NPs on the surfaces of SnD were reduced in-situ. X-Ray diffraction (XRD), Scanning electron microscope (SEM), Fourier transform infrared spectroscopy (FT-IR), transmission electron microscopy (TEM), and X-ray energy dispersive spectroscopy (EDS) were deployed for identifying the PrVO4/SnD. It is potentially a highly dynamic catalyst in the stabilization of CO2 for the production of 2-oxazolidinones and benzimidazoles. In addition, the catalyst is very easy to recycle and reuse without significant loss of active site Cu metal. Graphic Abstract: PrVO4/SnD NPs as a nanocatalyst for carbon dioxide fixation to synthesis benzimidazoles and 2-oxazolidinones. [Figure not available: see fulltext.]

CdSnO3/SnD NPs as a Nanocatalyst for Carbonylation of o-Phenylenediamine with CO2

Liu, Can,Sadeghzadeh, Seyed Mohsen

, p. 2807 - 2815 (2021/02/05)

In order to carbonize o-phenylenediamine with CO2, an effective approach was used with UV light irradiation by Sn(IV) doping DFNS (SnD) supported CdSnO3 as a catalyst (CdSnO3/SnD). In this catalyst, SnD with the ratios of Si/Sn in the range of 6 to 50 were obtained using the Direct Hydrothermal Synthesis (DHS), and the nanoparticles of CdSnO3 on the surfaces of SnD were reduced in situ. Scanning Electron Microscope (SEM), X-ray Diffraction (XRD), Fourier Transform Infrared Spectroscopy (FT-IR), X-ray Energy Dispersive Spectroscopy (EDS), and Transmission Electron Microscopy (TEM) were utilized for characterizing CdSnO3/SnD. It was found that CdSnO3/SnD nanostructures could be used for synthesizing o-phenylenediamines due to their effective and novel catalytic behavior through the reaction between o-phenylenediamines and CO2. Graphic Abstract: [Figure not available: see fulltext.]

Live-Cell Protein Modification by Boronate-Assisted Hydroxamic Acid Catalysis

Adamson, Christopher,Kajino, Hidetoshi,Kanai, Motomu,Kawashima, Shigehiro A.,Yamatsugu, Kenzo

supporting information, p. 14976 - 14980 (2021/09/29)

Selective methods for introducing protein post-translational modifications (PTMs) within living cells have proven valuable for interrogating their biological function. In contrast to enzymatic methods, abiotic catalysis should offer access to diverse and new-to-nature PTMs. Herein, we report the boronate-assisted hydroxamic acid (BAHA) catalyst system, which comprises a protein ligand, a hydroxamic acid Lewis base, and a diol moiety. In concert with a boronic acid-bearing acyl donor, our catalyst leverages a local molarity effect to promote acyl transfer to a target lysine residue. Our catalyst system employs micromolar reagent concentrations and affords minimal off-target protein reactivity. Critically, BAHA is resistant to glutathione, a metabolite which has hampered many efforts toward abiotic chemistry within living cells. To showcase this methodology, we installed a variety of acyl groups inE. colidihydrofolate reductase expressed within human cells. Our results further establish the well-known boronic acid-diol complexation as abona fidebio-orthogonal reaction with applications in chemical biology and in-cell catalysis.

Synthesis of novel halogenated heterocycles based on o‐phenylenediamine and their interactions with the catalytic subunit of protein kinase ck2

Maciejewska, Agnieszka Monika,Paprocki, Daniel,Poznański, Jaros?aw,Speina, El?bieta,Winiewska‐szajewska, Maria

supporting information, (2021/06/09)

Protein kinase CK2 is a highly pleiotropic protein kinase capable of phosphorylating hundreds of protein substrates. It is involved in numerous cellular functions, including cell viability, apoptosis, cell proliferation and survival, angiogenesis, or ER‐stress response. As CK2 activity is found perturbed in many pathological states, including cancers, it becomes an attractive target for the pharma. A large number of low‐mass ATP‐competitive inhibitors have already been developed, the majority of them halogenated. We tested the binding of six series of halogenated heterocyclic ligands derived from the commercially available 4,5‐dihalo‐benzene‐1,2‐diamines. These ligand series were selected to enable the separation of the scaffold effect from the hydrophobic interactions attributed directly to the presence of halogen atoms. In silico molecular docking was initially applied to test the capability of each ligand for binding at the ATP‐binding site of CK2. HPLC‐derived ligand hydrophobicity data are compared with the binding affinity assessed by low‐volume differential scanning fluorimetry (nanoDSF). We identified three promising ligand scaffolds, two of which have not yet been described as CK2 inhibitors but may lead to potent CK2 kinase inhibitors. The inhibitory activity against CK2α and toxicity against four reference cell lines have been determined for eight compounds identified as the most promising in nanoDSF assay.

Cytotoxic Ruthenium(II) Complexes of Pyrazolylbenzimidazole Ligands That Inhibit VEGFR2 Phosphorylation

Acharya, Moulinath,Chakraborty, Ayan,Chakraborty, Manas Pratim,Das, Rahul,Koley, Tuhin Subhra,Mukherjee, Arindam,Purkait, Kallol,Roy, Shantanu Saha,Roy, Souryadip

, p. 18379 - 18394 (2021/12/01)

Eight new ruthenium(II) complexes of N,N-chelating pyrazolylbenzimidazole ligands of the general formula [RuII(p-cym)(L)X]+ [where the ligand L is 2-(1H-pyrazol-1-yl)-1H-benzo[d]imidazole (L1) substituted at the 4 position of the pyrazole ring by Cl (L2), Br (L3), or I (L4) and X = Cl- and I-] were synthesized and characterized using various analytical techniques. Complexes 1 and 3 were also characterized by single-crystal X-ray crystallography, and they crystallized as a monoclinic crystal system in space groups P21/n and P21/c, respectively. The complexes display good solution stability at physiological pH 7.4. The iodido-coordinated pyrazolylbenzimidazole ruthenium(II) p-cymene complexes (2, 4, 6, and 8) are more resistant toward hydrolysis and have less tendency to form monoaquated complexes in comparison to their chlorido analogues (1, 3, 5, and 7). The halido-substituted 2-(1H-pyrazol-1-yl)-1H-benzo[d]imidazole ligands, designed as organic-directing molecules, inhibit vascular endothelial growth factor receptor 2 (VEGFR2) phosphorylation. In addition, the ruthenium(II) complexes display a potential to bind to DNA bases. The cytotoxicity profile of the complexes (IC50 ca. 9-12 μM for 4-8) against the triple-negative breast cancer cells (MDA-MB-231) show that most of the complexes are efficient. The lipophilicity and cellular accumulation data of the complexes show a good correlation with the cytotoxicity profile of 1-8. The representative complexes 3 and 7 demonstrate the capability of arresting the cell cycle in the G2/M phase and induce apoptosis. The inhibition of VEGFR2 phosphorylation with the representative ligands L2 and L4 and the corresponding metal complexes 3 and 7 in vitro shows that the organic-directing ligands and their complexes inhibit VEGFR2 phosphorylation. Besides, L2, L4, 3, and 7 inhibit the phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2) and proto-oncogene tyrosine-protein kinase (Src), capable of acting downstream of VEGFR2 as well as independently. Compounds L2, L4, 3, and 7 have a lesser effect on ERK1/2 and more prominently affect Src phosphorylation. We extended the study for L2 and 3 in the Tg(fli1:gfp) zebrafish model and found that L2 is more effective in vivo compared to 3 in inhibiting angiogenesis.

Design, Synthesis, Cytotoxicity, and Molecular Docking Studies of New Benzimidazole Hybrids as Possible Anticancer Agents

Mishra, Shashank Shekher,Sharma, C. S.

, p. 21 - 29 (2021/08/12)

In the course of efforts to develop new anticancer agents, benzimidazole-based morpholine, thiomorpholine, and piperazine hybrid compounds were designed and synthesized. The structures of the synthesized compounds were confirmed by Proton nuclear magnetic resonance, Carbon-13 NMR, and mass spectroscopy. The title compounds were screened for cytotoxicity against breast and lung cancer cell lines. Compound 6c was found most active against lung cancer cell line with IC50 value of 2.11 μM and compound 10c was found most active against breast cancer cell line with IC50 of 2.23 μM. The molecular docking analysis was also carried out to explore binding pattern of compound with the target protein. All synthesized compounds showed excellent binding affinity toward target protein. Therefore, these findings will be helpful in future drug design of more potent anticancer agents.

Method for preparing carbonyl heterocyclic compound

-

Paragraph 0036-0040, (2020/03/25)

The invention provides a method for preparing a carbonyl heterocyclic compound, wherein Lewis base and hydrosilane are used as accelerators and can efficiently enable an ortho-substituted aniline compound to react with normal-pressure CO2 to generate corresponding carbonyl heterocyclic compounds containing different functional groups under mild conditions (100 DEG C, digital). According to the method, normal-pressure CO2 is used as an environmentally-friendly non-toxic carbonylation reagent, and cheap Lewis base and PMHS (industrial silicon waste) are used as accelerators, so that the use of CO, high-pressure CO2 and noble metal catalysts is avoided, the intermediate isocyanate does not need to be purified and separated, the pure product can be obtained only through simple suction filtration and separation after the reaction is finished, and the synthetic method is efficient and universal, is suitable for preparing a series of benzimidazolone, benzoxazolone and benzothiazolone compounds and has high industrial application value.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 615-16-7